164 related articles for article (PubMed ID: 16730039)
1. TDR collaboration with the pharmaceutical industry.
Gutteridge WE
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S21-5. PubMed ID: 16730039
[TBL] [Abstract][Full Text] [Related]
2. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
3. Public-private partnership: from there to here.
Croft SL
Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
[TBL] [Abstract][Full Text] [Related]
4. Treatment of leishmaniasis with miltefosine: 2008 status.
Berman JJ
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
[TBL] [Abstract][Full Text] [Related]
5. [Oral miltefosine to treat leishmaniasis].
Soto J; Soto P
Biomedica; 2006 Oct; 26 Suppl 1():207-17. PubMed ID: 17361856
[TBL] [Abstract][Full Text] [Related]
6. [Leishmaniasis--oral treatment with hexadecylphosphocholine].
Bommer W; Eibl HJ; Engel KR; Kuhlencord A; Sindermann H; Sundar S; Zappel H
Wien Klin Wochenschr; 2004; 116 Suppl 4():24-9. PubMed ID: 15683039
[TBL] [Abstract][Full Text] [Related]
7. [Status of research and development for control of tropical diseases: hypocrisy, indifference or lack of coordination].
Millet P
Med Trop (Mars); 2006 Dec; 66(6):542-8. PubMed ID: 17286017
[TBL] [Abstract][Full Text] [Related]
8. [Miltefosine: a new remedy for leishmaniasis].
Dorlo TP; Eggelte TA; Beijnen JH; de Vries PJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2697-701. PubMed ID: 17194005
[TBL] [Abstract][Full Text] [Related]
9. Public / private partnership: developing an oral treatment for visceral leishmaniasis.
Mattock N
TDR News; 1999 Oct; (60):1-2. PubMed ID: 12295471
[TBL] [Abstract][Full Text] [Related]
10. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
11. Miltefosine: oral treatment of leishmaniasis.
Soto J; Soto P
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):177-85. PubMed ID: 16597200
[TBL] [Abstract][Full Text] [Related]
12. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
13. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.
Zerpa O; Ulrich M; Blanco B; Polegre M; Avila A; Matos N; Mendoza I; Pratlong F; Ravel C; Convit J
Br J Dermatol; 2007 Jun; 156(6):1328-35. PubMed ID: 17441955
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients.
Marques N; Sá R; Coelho F; Oliveira J; Saraiva Da Cunha J; Meliço-Silvestre A
Scand J Infect Dis; 2008; 40(6-7):523-6. PubMed ID: 18584541
[TBL] [Abstract][Full Text] [Related]
15. Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine.
Avasthi R; Chaudhary SC; Khanna S
Indian J Med Microbiol; 2009; 27(1):85-6. PubMed ID: 19172077
[No Abstract] [Full Text] [Related]
16. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
[TBL] [Abstract][Full Text] [Related]
17. Miltefosine Zentaris.
Kaminsky R
Curr Opin Investig Drugs; 2002 Apr; 3(4):550-4. PubMed ID: 12090722
[TBL] [Abstract][Full Text] [Related]
18. New treatment for leishmaniasis is 95% effective.
Bull World Health Organ; 2002; 80(8):688. PubMed ID: 12219169
[No Abstract] [Full Text] [Related]
19. Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis.
Ramesh V; Ansari NA; Jain RK; Salotra P
Clin Exp Dermatol; 2008 Jan; 33(1):103-5. PubMed ID: 17979988
[No Abstract] [Full Text] [Related]
20. Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines.
Nwaka S
Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S20-9. PubMed ID: 16085175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]